Pfizer Inc. (PFE) research: valuation against peers, fundamentals over time, risk and news coverage

PFE

Pfizer Inc.
USD
28.07
+1.01% today
Market cap
P/E trailing
P/E forward
EV/EBITDA
Op margin
Rev growth
Div yield
Beta
52-week range23.6028.551 report(s) in our archive
Price navigator — PFE

No data in this window.

    What PFE trades with

    The themes this instrument belongs to, and the rest of what sits inside them — the peer set a screener gives you is statistical, this one is editorial.

    Obesity drugs & pharma

    The GLP-1 duopoly, the challengers, and the sector they have been carrying.

    INDY NEWS coverage of PFE1

    Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.

    Full archive search for PFE

    Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.